INTERNATIONAL CELL SURGICAL SOCIETY
Data sourced from IRS 990 public filings
INTERNATIONAL CELL SURGICAL SOCIETY TO PROMOTE THE USE OF PROGENITOR/STEM CELLS AND OTHER CELLULAR THERAPIES IN THE TREATMENT OF DISEASE, TRAUMATIC INJURY AND CHRONIC PAIN; TO PROVIDE EDUCATION RELATED TO THIS TYPE OF MEDICAL TREATMENT AND THERAPIES; TO MAINTAIN AND PROMOTE LABORATORY PRACTICE AND CLINCIAL GUIDELINES RELATED TO THIS TYPE OF MEDICAL TREATMENT AND THERAPIES; AND TO DESIGN AND MANAGE AN ACCREDITATION PROGRAM TO EVALUATE CLINICS AND FACILITIES THAT PROVIDE THESE TYPES OF MEDICAL TREATMENTS AND THERAPIES.
Annual Revenue
$319,420
Known Funders
1
Grants Received
1
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $319,420 | $316,719 | $261,692 |
| 2023 | $301,083 | $318,832 | $268,992 |
| 2022 | $223,950 | $323,180 | $286,741 |
| 2021 | $309,552 | $295,420 | $386,871 |
| 2020 | $152,320 | $173,694 | $29,653 |
| 2019 | $278,066 | $322,446 | $34,825 |
| 2018 | $99,146 | $140,374 | $29,796 |
| 2017 | $91,782 | $141,875 | $31,055 |
Top Funders
INDIANAPOLIS, IN
Key Personnel
From 2024 IRS 990 filing
ELLIOT LANDER MD
PRESIDENT
Frequently Asked Questions
Other Nonprofits in California
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.